These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6547475)

  • 1. Evidence for multiple muscarinic receptor subtypes in human brain.
    Garvey JM; Rossor M; Iversen LL
    J Neurochem; 1984 Aug; 43(2):299-302. PubMed ID: 6547475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine.
    Lin SC; Olson KC; Okazaki H; Richelson E
    J Neurochem; 1986 Jan; 46(1):274-9. PubMed ID: 2866235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
    Messer WS; Ellerbrock BR; Smith DA; Hoss W
    J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain.
    Fisher SK; Bartus RT
    J Neurochem; 1985 Oct; 45(4):1085-95. PubMed ID: 2411866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of muscarinic receptors of the rabbit ear artery smooth muscle and endothelium.
    Hynes MR; Banner W; Yamamura HI; Duckles SP
    J Pharmacol Exp Ther; 1986 Jul; 238(1):100-5. PubMed ID: 3755169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light microscopic autoradiographic localization of [3H]pirenzepine and [3H](-)quinuclidinyl benzilate binding in human stellate ganglia.
    Yamamura HI; Watson M; Wamsley JK; Johnson PC; Roeske WR
    Life Sci; 1984 Aug; 35(7):753-7. PubMed ID: 6547993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties.
    Marchi M; Raiteri M
    J Pharmacol Exp Ther; 1985 Oct; 235(1):230-3. PubMed ID: 3840202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites.
    Nilvebrant L; Sparf B
    Eur J Pharmacol; 1986 Apr; 123(1):133-43. PubMed ID: 3754815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.